Pharmaceutical

Pfizer boasts over 30% increase in Q3 revenues against previous year

Amidst a share value slump and executive turmoil, Pfizer reported a robust quarter thanks in part to Covid-19 drug sales.

Nov 1, 2024 - 04:00
Pfizer boasts over 30% increase in Q3 revenues against previous year
Amidst a share value slump and executive turmoil, Pfizer reported a robust quarter thanks in part to Covid-19 drug sales.
Read the original article

Tags:

Previous Article

Will the tide turn for the wave of pharma layoffs?

Next Article

For pharma companies, the possibilities of green chemistry are huge

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT Wunderkinds discuss high-impact research, resilience, and social justice

STAT Wunderkinds discuss high-impact research, resilien...

Apr 29, 2023

FDA approves Roche’s Tecentriq Hybreza for cancer

FDA approves Roche’s Tecentriq Hybreza for cancer

Sep 14, 2024

STAT+: FTC plans to reverse years of policy statements supporting pharmacy benefit managers

STAT+: FTC plans to reverse years of policy statements ...

Jul 20, 2023